Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple [...]
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Saturday, May 31, 2014 Photos of the [...]
Workforce of the Future Spotlighted at MS Conference Foundation of CMSC Presents Record Number of Scholars and Awardees (Hackensack, [...]
Genzyme’s Lemtrada Resubmission Accepted for Review by FDA - Agency action expected in Q4 2014 - Cambridge, Mass. - May 30, 2014 - [...]
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses Friday, May 30, 2014 [...]
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Friday, May 30, 2014 Photos of the [...]
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Thursday, May 29, 2014 Photos of the [...]
Biogen Idec Announces Official Partnership with Sailing Sclerosis Oceans of Hope to Globally Change Perceptions of MS Wednesday, May [...]
EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Demonstrates Continued [...]
Contact:Â Annie Scully, 201-310-9252, annie.scully@mscare.org MEDIA ALERT Grow Your MS [...]